Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endometrial Neoplasms × Ado-Trastuzumab Emtansine × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Stomach Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Pleuropulmonary blastoma 1 Patient Preference 1 Pancreatic Neoplasms 1 Neurofibrosarcoma 1 Neuroblastoma 1 Multiple Myeloma 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 HER2-positive Breast Cancer 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

pembrolizumab 14 Paclitaxel 14 Carboplatin 10 Bevacizumab 6 rucaparib 5 lenvatinib 5 Megestrol Acetate 5 Radiation 4 Nivolumab 4 Indocyanine Green 4 tisotumab vedotin 3 temsirolimus 3 Sirolimus 3 Sentinel Lymph Node Biopsy 3 Doxorubicin 3 olaparib 2 ixabepilone 2 iso-sulfan blue 2 irosustat 2 epacadostat 2 durvalumab 2 copanlisib 2 Taxes 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ipilimumab 2 Gemcitabine 2 Fulvestrant 2 Cisplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡